Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 2.86 MYR
Change Today -0.02 / -0.69%
Volume 308.6K
As of 4:44 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

ccm duopharma biotech bhd (CCMD) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/21/15 - 3.04
52 Week Low
12/31/14 - 1.78
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

ccm duopharma biotech bhd (CCMD) Related Businessweek News

No Related Businessweek News Found

ccm duopharma biotech bhd (CCMD) Details

CCM Duopharma Biotech Berhad, an investment holding company, manufactures, distributes, imports, and exports pharmaceutical products and medicines in Malaysia. It offers various over the counter products, such as analgesic/anti-pyretics, children’s vitamins, cough preparations, dermatology products, eye drops, first aid dressings, health supplements, and pain relievers, and hand sanitizers. The company offers its products in various forms, including tablets, capsules, syrups, oral antibiotics, creams, haemodialysis solutions, sterile irrigation solutions, sterile powder injectables, small volume injectables, dental cartridges, and eye drop preparations. It exports its products to Vietnam, Ethiopia, Sudan, South East Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore, and Hong Kong. The company was founded in 1979 and is based in Klang, Malaysia. CCM Duopharma Biotech Berhad is a subsidiary of CCM Marketing Sdn. Bhd.

478 Employees
Last Reported Date: 04/30/15
Founded in 1979

ccm duopharma biotech bhd (CCMD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ccm duopharma biotech bhd (CCMD) Key Developments

CCM Duopharma Biotech Berhad to Invest Up to MYR 70 Million in Civil Infrastructure

CCM Duopharma Biotech Bhd (CCMD) will invest between MYR 40 million to MYR 70 million in civl infrastructure including for a new factory in Klang which will enable it to grow production capacity to three billion tablets a year from two billion tablets currently.

CCM Duopharma Biotech Berhad Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

CCM Duopharma Biotech Berhad reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenue of MYR 45,599,000 compared to MYR 40,495,000 a year ago. Profit from operations was MYR 12,160,000 compared to MYR 11,172,000 a year ago. Profit before taxation was MYR 12,198,000 compared to MYR 11,175,000 a year ago. Profit after tax for the period was MYR 8,969,000 compared to MYR 8,365,000 a year ago. Basic and diluted earnings per share were 6.43 sen compared to 6.03 sen a year ago. Net cash generated from operating activities was MYR 16,213,000 compared to MYR 3,489,000 a year ago. Acquisition of property, plant and equipment was MYR 6,203,000 compared to MYR 4,340,000 a year ago.

CCM Duopharma Biotech Berhad, Annual General Meeting, May 26, 2015

CCM Duopharma Biotech Berhad, Annual General Meeting, May 26, 2015., at 14:30 Singapore Standard Time. Location: premiere Hotel, Bandar Bukit Tinggi. Agenda: To consider and receive and adopt the audited financial statements for the financial year ended 31 December 2014 together with the reports of the directors and auditors thereon; to consider approve a final dividend of 14.5 sen per ordinary share, tax exempt dividend under single tier tax system for the financial year ended 31 December 2014; to consider and re-elect datuk alias bin ali who retires in accordance with article 93 of the articles of association of the company; to consider and re-appoint Messrs KPMG as auditors of the company and to authorize the directors to fix their remuneration; to consider renewal of existing shareholders mandate and proposed new shareholders mandate for recurrent related party transactions of a revenue of trading nature; to consider retention of dato' haji ghazall bin awang and tan sri dato' dr. jegathesan a/l n.m. vasagam @ manikavasagam as independent directors of the company; and to consider other matter also.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCMD:MK 2.86 MYR -0.02

CCMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CCMD.
View Industry Companies

Industry Analysis


Industry Average

Valuation CCMD Industry Range
Price/Earnings 10.7x
Price/Sales 2.1x
Price/Book 1.9x
Price/Cash Flow 21.6x
TEV/Sales 4.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CCM DUOPHARMA BIOTECH BHD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at